Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07440472

A Study on Remote Health Support for Patients With Heart Failure.

This multicenter prospective observational feasibility study evaluates the implementation of the RAPHAEL model, a remote monitoring palliative care approach for patients with heart failure. The study aims to assess the feasibility, acceptability, usability, and implementation outcomes of integrating structured remote symptom monitoring and palliative care needs assessment into routine outpatient heart failure care.

Adult patients with heart failure and worsening symptoms and/or potential palliative care needs will complete a structured digital questionnaire during a 4-week follow-up period. Healthcare professionals will review reported needs and conduct follow-up contact according to usual clinical practice. No experimental drugs or devices are administered, and clinical management remains at the discretion of the treating team.

Primary outcomes focus on feasibility and implementation metrics, including participation rates, acceptability, usability, perceived burden, resource requirements, fidelity to the intervention model, training adoption, applicability, adaptation, and demand.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitaetsklinikum Aachen, Aachen, Germany

Loading trial locations.

About this study

The RAPHAEL study (Work Package 4) is a multicenter, prospective observational feasibility study conducted across participating European clinical sites. The objective is to evaluate the implementation of a structured remote monitoring palliative care model integrated into routine outpatient heart failure care.

Patients with a confirmed diagnosis of heart failure who present with worsening symptoms and/or indicators of palliative care needs will be invited to participate. Participants will complete a structured digital questionnaire designed to identify symptom burden, psychosocial concerns, and potential unmet palliative care needs. The questionnaire is administered once during a 4-week observation period.

Healthcare professionals trained in the RAPHAEL model will review questionnaire responses and may initiate follow-up contact or clinical actions according to standard clinical judgment and existing care pathways. The study does not mandate changes to pharmacological treatment, and all medical decisions remain under routine clinical practice.

The primary objective is to assess feasibility and implementation outcomes, including recruitment capability, participation rates, acceptability, usability, perceived burden for patients and professionals, fidelity to the intervention components, required resources, adaptation processes, and demand. Secondary objectives include descriptive assessment of symptom burden and identified palliative care needs.

The study is classified as an observational prospective study according to ethics committee approval. No randomization, experimental interventions, or investigational medicinal products are involved.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients

  • Adult patients (≥18 years) with the main diagnosis of HF according to current guidelines (20), living at home; recruitment will be stratified by sex and limited to 60-70% for either sex.
  • Screen positive for one of the three clinical "sensitizing" questions, intended to identify potential palliative care (PC) needs:

'Would I be surprised if this patient were to die within one year?'

  • A "No" response indicates possible palliative care needs. 'Has this patient experienced 'escalating care events' at least twice in the past year, including i) unscheduled hospitalizations for HF, ii) emergency department visits for HF, iii) visits to out-of-hours primary care services for HF, and/or iv) other similar escalating care events?'
  • A "Yes" response indicates possible PC needs. 'Is this patient experiencing persistent or worsening multidimensional symptoms (e.g., physical, psychological, social, or spiritual concerns) despite optimal HF treatment, such that a palliative assessment is indicated (upon discretion of the treating physician or nurse)?'
  • A "Yes" response indicates possible PC needs.
  • patient's or informal caregiver's ability to use technology (e.g., having internet access, owning a smartphone or tablet, or having someone available who can assist them).
  • capacity to provide informed consent.

Primary Caregiver:

  • Informal caregiver who is present with the patient during the implementation of the intervention
  • ≥18 years
  • capacity to provide consent.

Healthcare professionals: Two professionals identified by the consortium in each site, willing to be trained in the intervention to perform the feasibility study.

Exclusion criteria

  • Acute events leading to multiple outpatient visits not related to the HF diagnosis.
  • severe cognitive impairment or language disorders as determined by the attending healthcare professional based on clinical judgment and medical record review.
  • simultaneous participation in another study.
  • inability to read and write in the language in which the study is conducted.

Primary caregivers:

  • Cognitive impairment or language disorders determined by the attending healthcare professional.
  • inability to read and write in the language in which the study is conducted.

Health care professionals: a) Inability to read and write fluently in the language(s) required for the study site and for using the digital questionnaire.

Treatment and study plan

Primary outcomes

  1. Participation Rate Among Eligible Patients

    Time frame: 4 weeks

    Participation will be measured as the proportion of eligible patients with heart failure who provide informed consent and enroll in the RAPHAEL intervention during the 4-week observation period. Unit of Measure: Percentage (%) Calculated as follows:

    Numerator: Number of eligible patients who provide written informed consent and are enrolled.

    Denominator: Total number of eligible patients approached for participation by healthcare professionals.

    The prespecified feasibility criterion for success is a participation rate greater than 60%.

Secondary outcomes

  1. Acceptability of the RAPHAEL Model

    Time frame: 4 weeks

    Patient-reported acceptability of the digital questionnaire and follow-up process assessed using structured evaluation questions at the end of the 4-week observation period. It will be evaluated using a Likert scale (0 - Completely inappropriate, 1 - Rather inappropriate, 2 - Rather appropriate, 3 - Completely appropriate). A 4-point scale was selected to minimize respondent burden and to facilitate cross-country comparability, while still capturing meaningful differences in perception. Criterion: ≥ 75% of patients score ≥ 2.

  2. Usability of the Digital Questionnaire

    Time frame: 4 weeks

    Participant-reported usability of the structured digital questionnaire, including ease of use and clarity of questions, assessed at the end of the observation period. It will be evaluated using a dichotomous answer (yes/no). Criterion: ≥ 75% of patients consider the intervention to be easy to use.

  3. Perceived Burden

    Time frame: 4 weeks

    Patient-reported perceived burden associated with completing the questionnaire and participating in the study procedures. This will be measured using a Likert scale (0 - no burden, 1 - Light burden, 2 - Moderate burden, 3 - Heavy burden). Criterion: ≥ 75% of participants rate the burden as ≤ 1.

  4. Fidelity to the RAPHAEL Model

    Time frame: 4 weeks

    Proportion of cases in which healthcare professionals reviewed questionnaire responses and documented follow-up actions according to the study framework. Criterion: ≥ 80% of the patients complete the 4 steps of the RAPHAEL intervention during their enrollment.

  5. Healthcare Professional Adoption

    Time frame: 4 weeks

    Assessment of healthcare professional engagement with and adoption of the RAPHAEL model during the study period. Criterion: all participating healthcare professionals complete the final assignment of the online training.

Study contacts

Contact information is provided by the study sponsor or research team.

Cristina Monforte, Phd

CONTACT

[email protected]

+34652428214

Sponsors and collaborators

Lead sponsor

Universitat Internacional de Catalunya

Other

Collaborators

  • Althaia Xarxa Assistencial Universitària de Manresa
  • Centre Hospitalier Universitaire Vaudois
  • European Association for Palliative Care
  • IRIS-CC
  • Linkoeping University
  • Maastricht University Medical Center
  • UMC Utrecht
  • University College London Hospitals
  • University Hospital, Aachen
  • University of Humanistic Studies
  • University of Leeds
  • University of Vic - Central University of Catalonia
  • Università degli Studi di Brescia
  • Vilnius University
  • Wroclaw Medical University

Registry information

Official study title

Feasibility of Implementing a Remote Monitoring Palliative Care Model for Patients With Heart Failure.

Acronym: RAPHAEL

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 27, 2026
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.